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Nuclear export signalThe Us3 serine/threonine kinase encoded by all alphaherpesviruses performs several important functions
during virus multiplication. For example, expression of pseudorabies virus (PRV) Us3 causes reorganization
of the actin cytoskeleton into ﬁlamentous processes (FPs) that promote cell-to-cell spread of virus infection.
PRV Us3-induced FP formation requires Us3 kinase activity. To determine whether these characteristics were
shared by HSV-2 Us3, expression plasmids for wild type (WT) and kinase dead (KD) Us3 variants were
constructed. Expression of WT Us3 resulted in robust FP formation whereas expression of the KD Us3
variants did not. In the course of these experiments we noted that KD/K220 mutant Us3s were excluded
from the nucleus in comparison to WT or KD/D305A Us3, prompting us to investigate Us3 nuclear shuttling
properties. Herein we describe determinants of HSV-2 Us3-induced FP formation and present evidence for
the presence of a leucine-rich nuclear export signal within HSV-2 Us3.
© 2009 Elsevier Inc. All rights reserved.Introduction
Herpes simplex virus type 2 (HSV-2) is a member of the
alphaherpesvirus subfamily of the Herpesviridae and is the primary
causative agent of genital herpes. Like all alphaherpesviruses, HSV-2
encodes a serine/threonine kinase in the unique short region of its
genome, designated Us3. Us3 has several known functions in
alphaherpesvirus biology including prevention of virus-induced apo-
ptosis (Geenen et al., 2005; Hata et al., 1999; Leopardi et al., 1997; Ogg
et al., 2004), virionmaturation (Reynolds et al., 2002; Schumacher et al.,
2005; Wagenaar et al., 1995) and cell-to-cell spread of virus infection
(Demmin et al., 2001; Favoreel et al., 2005). Expression of the Us3 gene
from HSV-2, as well as Us3 genes from the related alphaherpesviruses
pseudorabies virus (PRV) and Marek's disease virus (MDV), results in
alterations in the actin cytoskeleton (Calton et al., 2004; Murata et al.,
2000; Schumacher et al., 2005; Van Minnebruggen et al., 2003, 2002).
These cytoskeletal alterations include disassembly of actin stress ﬁbres
(Schumacher et al., 2005; Van Minnebruggen et al., 2003), and, in the
case of PRV, formation of long ﬁlamentous processes (FPs) that are
believed to facilitate the spread of virus to non-adjacent cells (Favoreel
et al., 2005). Us3 kinase activity has been shown to be required for the
cytoskeletal remodeling caused byHSV-2 Us3 (Murata et al., 2000) and
PRVUs3 (Van den Broeke et al., 2009a) but is not required in the case of
MDVUs3 (Schumacher et al., 2008). Recently, it has beendemonstrated
that the group I p21-activated kinases PAK1 and PAK2 play an essential
role in PRVUs3-induced remodeling of the actin cytoskeleton (Van den
Broeke et al., 2009b).nﬁeld).
ll rights reserved.We wished to establish whether HSV-2 Us3 was capable of
remodeling the actin cytoskeleton into FPs in transiently transfected
cells and, if so, whether disruption of kinase activity in HSV-2 Us3
would correlate with disruption of FP formation. During the course of
investigating these properties, we observed a striking difference in the
subcellular localization of one of our kinase dead (KD) versions of HSV-
2Us3. This observationpromptedus to investigate thenuclear shuttling
properties of Us3. In this communication, we describe determinants of
HSV-2Us3-induced FP formationandpresent evidence for the presence
of a leucine-rich nuclear export signal within HSV-2 Us3.
Results
Expression of HSV-2 Us3 in transfected cells results in FP formation
To enable the detection of HSV-2 Us3 in transfected cells, rat
polyclonal antiserum was raised against a GST-HSV-2 Us3 fusion
protein produced by recombinant baculoviruses. This antiserum
detected a protein slightly larger than the predicted molecular weight
for HSV-2 Us3 (53 kDa) in extracts prepared from 293T cells
transfected with a HSV-2 Us3 expression construct (Fig. 1A, lane 1)
as well as in extracts prepared from Vero cells infected with HSV-2
(Fig. 1B, lane 3). This antiserum was also able to detect HSV-1 Us3
(Fig. 1B, lane 2).
To determine whether HSV-2 Us3 was capable of eliciting FP
formation, Vero cells were transfectedwith a plasmid encoding HSV-2
Us3, along with a plasmid encoding the red ﬂuorescent protein
mCherry (Shaner et al., 2004), to aid in identifying transfected cells,
then stained with HSV-2 Us3 antiserum and examined by confocal
microscopy. HSV-2 Us3 could be detected in both the nucleus and the
Fig. 1. Polyclonal antiserum from rats immunized with GST-HSV-2 Us3 speciﬁcally
detects HSV-2 Us3. (A) Equal volumes of cellular extracts prepared from 293T cells
transfected with a plasmid encoding HSV-2 Us3 (lane 1), GFP (lane 2), or HSV-2 Us3-
GFP (lane 3) were analyzed by Western blotting. The upper panel was probed with rat
polyclonal HSV-2 Us3 antiserum and the loading control in the lower panel was probed
with anti-actin monoclonal antibody. No bands were detected in lane 2 of the upper
panel (including bands smaller than 58 kDa, which are not shown). The major band
detected in lane 1 is slightly larger than the predicted molecular weight of HSV-2 Us3
(53 kDa). Note the shift in molecular weight of the detected band in cells transfected
with plasmid encoding HSV-2 Us3-GFP fusion protein. (B) Equal volumes of cellular
extracts prepared from mock-infected (lane 1), HSV-1 17+-infected (lane 2), or HSV-2
HG52-infected Vero cells (lane 3) were analyzed by Western blotting. The upper panel
was probed with rat polyclonal HSV-2 Us3 antiserum, the loading control in the middle
panel was probed with anti-actin monoclonal antibody, and the infection control in the
lower panel was probed with anti-HSV-2 ICP5. Molecular size markers indicated at the
left of each upper panel are in kilodaltons.
Fig. 2. Expression of HSV-2 Us3 in transfected cells results in FP formation. (A)
Representative images of FPs formed in Vero cells transfected with plasmids encoding
HSV-2 Us3, mCherry fusions to HSV-2 Us3 or mCherry alone. In the upper left panel,
staining with polyclonal antiserum speciﬁc for HSV-2 Us3 followed by staining with an
Alexa 488 conjugated secondary antibody was used to detect cells expressing HSV-2
Us3. Stained cells were examined by confocal microscopy. (B) Percentage of transfected
cells with FPs. Fifty independent ﬁelds of cells containing at least one transfected cell
were scored for the presence or absence of FPs. Results from two independent
experiments are shown. Numbers of cells scored in experiment 1 and experiment 2
were as follows: for WT Us3, 115 and 127; for mCherry-Us3, 145 and 156; for Us3
mCherry, 168 and 154; for mCherry, 206 and 164.
24 R.L. Finnen et al. / Virology 397 (2010) 23–33cytoplasm in transfected cells (Fig. 2A; see also Figs. 5B and 6). By 24 h
post transfection, the majority of transfected cells had formed long
FPs, depicted in Fig. 2A, similar to those we have observed previously
with PRV Us3 (Calton et al., 2004). The length of the FPs formed was
often greater than the length of one cell and elaborate branching of
FPs was commonly observed. FPs with similar characteristics were
also observed in cells transfected with plasmids encoding HSV-2 Us3
mCherry fusion proteins (denoted mCherry-Us3 and Us3-mCherry in
Fig. 2A) and in cells transfected with a plasmid encoding HSV-2 Us3
with GFP fused to the C-terminus (data not shown). In addition,
comparable numbers of transfected cells with FPs were seen in cells
transfected with plasmids encodingmCherry-fused and unfused HSV-
2 Us3 (Fig. 2B). These data demonstrate that transient expression of
HSV-2 Us3 in cells results in FP formation and that fusion of a
ﬂuorescent protein tag to either end of HSV-2 Us3 does not impede its
ability to induce FP formation.
Actin polymerization contributes to HSV-2 Us3-induced FP formation
To investigate the speciﬁc involvement of actin polymerization in
FP formation, Vero cells were transfected with a plasmid encoding
HSV-2 Us3 and subsequently incubated with 1 μM cytochalasin D.
Filamentous actin was detected using Texas red conjugated phalloidin
andmicrotubules were detected using a monoclonal antibody speciﬁc
for β-tubulin. The percentage of transfected cells with FPs was
diminished in the presence of 1 μM cytochalasin D as compared to
cells treated with carrier (0.01% DMSO) (Fig. 3A) indicating that the
ability to polymerize actin contributes to HSV-2 Us3-induced FP
formation. In keeping with previous studies on HSV-2 Us3 (Murata etal., 2000), transfected cells consistently displayed amarked disruption
in actin stress ﬁbres; actin stress ﬁbre breakdown occurred regardless
of whether the transfected cell had formed FPs (data not shown). By
contrast, microtubules in transfected cells remained intact (Fig. 3B).
FPs induced by HSV-2 Us3 contained both actin and β-tubulin
(Fig. 3B), as has been observed previously with FPs induced by PRV
Us3 (Calton et al., 2004). Thus, the reorganization of the actin
cytoskeleton into FPs that contain both actin and microtubules is a
common consequence of the expression of PRV and HSV-2 Us3.
Us3 kinase activity is required for HSV-2 Us3-induced FP formation and
actin stress ﬁbre breakdown
As stated above, the requirement for Us3 kinase activity in Us3-
induced cytoskeletal alterations varies between the alphaherpes-
viruses (Murata et al., 2000; Schumacher et al., 2008; Van den Broeke
et al., 2009a). Thus, we wished to establish whether disruption of
Fig. 3. FP formation in the presence of cytochalasin D. (A) Percentage of transfected cells with FPs. Vero cells were transfected with a plasmid encoding HSV-2 Us3. At 6 h post
transfection cells were placed in medium containing 1 μM cytochalasin D or 0.01% DMSO (carrier). Cells were incubated in the continuous presence of drug or carrier for 12 h, then
ﬁxed and stained with rat polyclonal antiserum speciﬁc for HSV-2 Us3 and mouse monoclonal antibody speciﬁc for β-tubulin, followed by staining with Alexa 488 conjugated
donkey anti-rat and Alexa 647 conjugated donkey anti-mouse secondary antibodies. Filamentous actin was detected using Texas Red conjugated phalloidin. Stained cells were
examined by confocal microscopy and 50 independent ﬁelds of cells containing at least one transfected cell were scored for the presence or absence of FPs. Results from two
independent experiments are shown. Numbers of cells scored in experiment 1 and experiment 2 were as follows: for Us3-transfected cells treated with DMSO carrier, 110 and 167;
for Us3-transfected cells treated with cytochalasin D, 112 and 125. (B) Representative images of transfected cells used in this analysis. Arrows indicate actin stress ﬁbres and
arrowheads indicate FPs that contain both actin and β-tubulin. Note that actin stress ﬁbres, but not microtubules, are markedly disrupted in cytochalasin D-treated cells.
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formation and/or actin stress ﬁbre breakdown. Previous work
correlating HSV-2 Us3 kinase activity with cell rounding, an indirect
read-out of actin stress ﬁbre disruption, had utilized kinase dead (KD)
versions of HSV-2 Us3 carrying large deletions (Murata et al., 2000).
We wished to construct KD versions of HSV-2 Us3 carrying more
precise disruptions in kinase activity. Two different KD versions of
HSV-2 Us3 were constructed for our initial investigations. Serine–
threonine kinases, including HSV-1 Us3, have been subdivided into 11
subdomains, designated I through XI (Hanks et al., 1988). Subdomain
II contains a conserved lysine that is required for catalytic activity
(Hanks and Hunter, 1995; Hanks et al., 1988; Kato et al., 2005; Mou
et al., 2007); subdomain VI contains a conserved aspartic acid that is
similarly required for catalytic activity (Hanks and Hunter, 1995;
Hanks et al., 1988; Knighton et al., 1991). By alignment with HSV-1
Us3, we identiﬁed the invariant lysine and aspartic acid in HSV-2 Us3
and changed lysine 220 to methionine (KD/K220M) and aspartic acid
305 to alanine (KD/D305A).
It is well established that mutation of HSV-1 Us3 K220 (K220A or
K220M) results in a catalytically inactive enzyme (Kato et al., 2005;
Mou et al., 2007). To conﬁrm that the D305A version of HSV-2 Us3 we
constructed lacked kinase activity, whole-cell extracts prepared fromVero cells transfected with plasmids encodingWT or KD/D305A were
analyzed by Western blotting using antisera reactive against protein
kinase A (PKA) substrates (Fig. 4). Because of the considerable
homology between Us3 and PKA phosphorylation sites, this antisera
has been used to detect Us3 speciﬁc kinase activity (Benetti and
Roizman, 2004). Similar levels of phosphorylation were observed in
cell lysates prepared from Vero cells transfected with either empty
vector or the D305A mutant (Fig. 4, lanes 1 and 3). By contrast,
expression of WT Us3 resulted in both an increase in the number of
phosphorylated proteins detected as well as a marked increase in
signal intensity (Fig. 4, lane 2). These data indicate that D305A lacks
kinase activity.
Vero cells were transfected with plasmids encoding WT or KD
versions of HSV-2 Us3, stained with HSV-2 Us3 antiserum at 24 h post
transfection and then examined by confocal microscopy. The
percentage of transfected cells with FPs was diminished in cells
transfected with plasmids encoding either KD version of HSV-2 Us3 in
comparison to cells transfected with a plasmid encoding WT HSV-2
Us3 (Fig. 5A). Similar reductions in FP formationwere also observed in
cells transfected with KD mCherry-Us3 or GFP fusion proteins (data
not shown). The FPs present in cells transfected with plasmids
encoding either KD version of HSV-2 Us3 were shorter and tended to
Fig. 4. HSV-2 Us3 kinase activity is disrupted in a D305A mutant. Equal volumes of
cellular extracts prepared from Vero cells transfected with pCINeo vector (lane 1), a
plasmid encoding WT HSV-2 Us3 (lane 2), or a plasmid encoding a D305A mutant of
HSV-2 Us3 (lane 3) were analyzed by Western blotting. The upper panel was probed
with Phospho-(Ser/Thr) PKA substrate antibody, the middle panel was probed with rat
polyclonal HSV-2 Us3 antiserum and the loading control in the lower panel was probed
with anti-actin monoclonal antibody. Molecular size markers indicated at the left of the
panel are in kilodaltons.
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plasmid encoding WT HSV-2 Us3. Consistent with previous work on
HSV-2 Us3 (Murata et al., 2000), KD versions did not generally cause
cell rounding and breakdown of actin stress ﬁbres (Fig. 6). Thus, in
terms of the requirement for kinase activity in Us3-induced
cytoskeletal alterations, HSV-2 is more similar to PRV than MDV.
Nuclear localization of WT and KD versions of HSV-2 Us3 in
transfected cells
During our characterization of KD versions of HSV-2 Us3, we noted
that KD/K220M Us3 often appeared to be excluded from the nucleus
of transfected Vero cells, particularly in cells displaying robust
expression (Fig. 5B). Nuclear exclusion of KD/K220M Us3 was also
observed in transfected 293T and HeLa cells (data not shown) and in
cells transfected with plasmids encoding KD/K220M Us3-mCherry
fusion proteins (Fig. 7). To quantify this observation, 50 independent
ﬁelds of cells transfected with plasmids encodingWT, KD/K220M and
KD/D305A HSV-2 Us3 were scored for whether Us3 appeared to be
excluded from the nucleus (the staining pattern designated with an
arrow in Fig. 5B) or whether Us3 could be detected in both nucleus
and the cytoplasm (the staining pattern designated with an
arrowhead in Fig. 5B). In the majority of cells transfected with a
plasmid encoding KD/K220MUs3 (93 out of 151 cells in experiment 1
and 117 out of 179 cells in experiment 2), Us3 appeared to be
excluded from the nucleus. This was in sharp contrast to cells
transfected with either WT or KD/D305A Us3, where nuclear
exclusion was rarely observed (3 out of 111 cells or 4 out of 138
cells, respectively, in experiment 1 and 0 out of 124 cells or 8 out of
163 cells, respectively, in experiment 2). To determine whether the
loss of a lysine or conversely, the introduction of a methionine, was
responsible for the subcellular localization pattern of K220M, we
constructed and analyzed a K220A version of HSV-2 Us3. The
subcellular localization pattern of this mutant resembled that of
K220M (data not shown). Collectively, these data indicate that
mutation of K220, independent of the loss of kinase activity,
inﬂuences the nuclear localization of HSV-2 Us3. To determine
whether this is a common feature of alphaherpesvirus Us3 ortholo-
gues, the corresponding mutation was made in PRV Us3 (KD/K137MUs3) and the mutated protein was fused to monomeric red
ﬂuorescent protein (mRFP1) (Campbell et al., 2002) to enable its
detection in transfected cells. Nuclear exclusion was not observed in
cells transfectedwith a plasmid encoding PRV KD/K137M-mRFP1 Us3
(Fig. 7). Thus the involvement of this lysine in nuclear localization
may not apply to all alphaherpesvirus Us3 proteins.
Evidence for the presence of a leucine-rich nuclear export signal in
HSV-2 Us3
The aberrant subcellular localization pattern of Us3 in cells
transfected with KD/K220M Us3 prompted us to explore the nuclear
shuttling properties of HSV-2 Us3. Conceivably, inhibition of nuclear
import of Us3 and/or increase in nuclear export of Us3 could cause
Us3 to preferentially accumulate in the cytoplasm. Inspection of the
primary amino acid sequence of HSV-2 Us3 did not reveal the
presence of lysine/arginine-rich motif conforming to a consensus
single or bipartite nuclear localization signal (Dingwall et al., 1982;
Kalderon et al., 1984; Robbins et al., 1991). However, HSV-2 Us3
contains two potential leucine-rich nuclear export signals (NESs)
(Bogerd et al., 1996) located within the vicinity of valine 250 (Fig. 8A),
a residue that is predicted to be part of a leucine-rich NES as
determined by the NetNES 1.1 algorithm (la Cour et al., 2004). Both
potential NESs are identical in HSV-1 Us3 (Fig. 8B). Although the
presence of potential leucine-rich NESs in the same region of Us3
orthologues of other alphaherpesviruses was variable, the key
hydrophobic residues at the beginning of the ﬁrst potential NES and
the end of the second potential NES were well conserved (Fig. 8B).
Export of protein from the nucleus via leucine-rich NESs is known
to be sensitive to leptomycin B (LMB) (Fornerod et al., 1997; Wolff et
al., 1997). To test whether HSV-2 Us3 subcellular localization was
affected by LMB, Vero cells were transfected with plasmids encoding
KD/K220M or KD/D305A Us3 and cells were subsequently incubated
with 10 nM LMB or 0.07% methanol (carrier) for 16 h. We utilized KD
versions of HSV-2 Us3 for our initial analysis to ensure that
transfected cells would remain ﬂat and thus allow better imaging of
the subcellular distribution of Us3. In many of the cells treated with
LMB (46 out of 100 cells and 56 out of 100 cells for KD/K220M and
KD/D305A, respectively), Us3 was located predominately within the
nucleus (Fig. 9, “+ LMB” panels). This staining pattern was more
rarely observed in cells treated with carrier (2 out of 100 cells and 12
out of 100 cells for KD/K220M and KD/D305A, respectively). Thus the
subcellular localization pattern of KD HSV-2 Us3 is sensitive to LMB,
consistent with the presence of a leucine-rich NES within this protein.
Based on the above ﬁndings, we reasoned that LMB treatment
might provide a means for distinguishing the roles of nuclear and
cytoplasmic HSV-2 Us3 in FP formation. Vero cells were transfected
with a plasmid encoding WT HSV-2 Us3 and cells were subsequently
incubated with 10 nM LMB or carrier for 16 h. Transfected cells were
then examined for the subcellular localization of Us3 and for the
presence or absence of FPs. The percentage of Us3-transfected cells
with FPs was diminished in the presence of 10 nM LMB as compared
to cells treated with carrier (Fig. 10A). The percentage of mCherry-
transfected cells with FPs did not change in the presence of 10 nM
LMB. Moreover, the FPs formed in the presence of LMB tended to be
shorter and much less elaborate than FPs formed in the presence of
carrier. In a large proportion of cells treated with LMB (68 out of 101
cells and 71 out of 106 cells in the experiment reported in Fig. 10A),
Us3 was located predominately within the nucleus (as depicted in
Fig. 10B, “+ LMB” panel); this staining pattern was more rarely
observed in cells treated with carrier (8 out of 137 cells and 9 out of
135 cells in the experiment reported in Fig. 10A). Furthermore, the
vast majority of cells with Us3 located predominately within the
nucleus lacked FPs (55 out of 68 cells and 55 out of 71 cells in the LMB-
treated cells in the experiment reported in Fig. 10A). These data
indicate that LMB treatment has an adverse effect on HSV-2 Us3-
Fig. 5. Us3 kinase activity is required for HSV-2 Us3-induced FP formation. (A) Percentage of transfected cells with FPs. Vero cells were transfected with plasmids encoding the
indicated proteins. At 24 h post transfection, cells were ﬁxed and stained with rat polyclonal antiserum speciﬁc for HSV-2 Us3 followed by staining with an Alexa 488 conjugated
donkey anti-rat secondary antibody. Nuclei were stained with Hoechst 33342. Stained cells were examined by confocal microscopy and 50 independent ﬁelds of cells containing at
least one transfected cell were scored for the presence or absence of FPs. Results from two independent experiments are shown. Numbers of cells scored in experiment 1 and
experiment 2 were as follows: for WT, 111 and 124; for KD/K220M, 151 and 179; for KD/D305A, 138 and 163; for mCherry, 123 and 187. (B) Representative images of transfected
cells used in this analysis. Arrow and arrowhead indicate the two different subcellular localization patterns of Us3 observed in cells transfected with a plasmid encoding KD/K220M
Us3. Scale bar is 10 μm.
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HSV-2 Us3 is speciﬁcally involved in actin cytoskeleton remodeling.
Thus, subcellular localization can be included along with kinase
activity as determinants of HSV-2 Us3-induced FP formation.
To determine if there was evidence for a functional Us3 NES in
virally infected cells, we examined Us3 localization in HSV-2 infected
Vero cells in the presence and absence of LMB. Vero cells growing on
glass bottom dishes were infected with HSV-2 (HG52) at a
multiplicity of infection of 10. At 2 h post infection either 10 nM
LMB or carrier (0.07% methanol) was added to the cells and the
infection was allowed to proceed until 8 h post infection. Cells were
then ﬁxed and stained for Us3 and ICP8, an early viral protein that
localizes to the nucleus (Fenwick et al., 1978; Knipe and Spang, 1982;
Quinlan et al., 1984) (Fig. 11). In the absence of LMB, Us3 was
distributed throughout the nucleus and cytoplasm as well as to smallpunctate cytoplasmic structures reminiscent of those seen in PRV
infected cells stained with Us3 antiserum (Lyman et al., 2003). In the
presence of LMB, Us3 appeared predominantly nuclear in many
infected cells. The Us3 localization differences observed in infected
cells in the presence of LMB were less dramatic than was observed in
Us3-transfected cells in the presence of LMB. Nevertheless, our results
with infected cells are in keeping with our results with transfected
cells and consistent with the idea that Us3 shuttles between the
nucleus and cytoplasm during viral infection.
Discussion
These investigations were initiated with the goal of establishing
whether HSV-2 Us3 was able to induce FP formation as we, and others,
have demonstrated for PRV Us3 (Calton et al., 2004; Favoreel et al.,
Fig. 6. Us3 kinase activity is required for HSV-2 Us3-induced actin stress ﬁbre breakdown. Vero cells were transfected with plasmids encoding WT, KD/K220M or KD/D305A Us3. At
24 h post transfection, cells were ﬁxed and stained with rat polyclonal antiserum speciﬁc for HSV-2 Us3 followed by staining with an Alexa 488 conjugated donkey anti-rat secondary
antibody. Filamentous actin was detected using Texas Red conjugated phalloidin and nuclei were stained with Hoechst 33342. Stained cells were examined by confocal microscopy.
Representative images are shown. Arrows indicate actin stress ﬁbres. Scale bar is 10 μm.
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consequence of HSV-2 Us3 expression and, furthermore, that Us3
kinase activity is required for FP formation. During the course of
determining the requirement for kinase activity in FP formation, we
noted that a KD version of HSV-2 Us3, in which a lysine in catalytic
subdomain II (Hanks et al., 1988) was changed to methionine (KD/
K220M), was often excluded from the nucleus. Exclusion of Us3 from
thenucleuswas also apparent inHSV-2Us3mutants carrying adeletion
encompassing catalytic subdomains I and II (Murata et al., 2000).
Nuclear exclusion was not observed with a distinct KD HSV-2 Us3 in
whichanaspartic acid in catalytic subdomainVIwas changed to alanine
(KD/D305A). These data indicate that the K220Mmutation, rather than
loss of kinase activity, is responsible for the aberrant subcellular
localization. Furthermore, the localization of the Us3 K220A mutant
resembled that of the Us3 K220Mmutant, suggesting that it is the lossFig. 7. Subcellular localization of PRV KD/K137M Us3. Vero cells were transfected with plas
post transfection, cells were ﬁxed, nuclei were stained with Hoechst 33342 and examinedof a lysine at position 220 rather than the gain of a methionine that is
responsible for nuclear exclusion of HSV-2 Us3. Thus, we have
identiﬁed a single amino acid in HSV-2 Us3 that is involved in nuclear
localization. A determinant of nuclear export of HSV-2 Us3 was also
identiﬁed in these studies. The results of our experiments with LMB, a
speciﬁc inhibitor of nuclear export via leucine-rich NESs (Wolff et al.,
1997), in both transfectedand infected cells provide strongevidence for
the presence of a leucine-rich NES in HSV-2 Us3.
It is well established that the Us3 kinase plays a variety of roles in
alphaherpesvirus multiplication (Demmin et al., 2001; Favoreel et al.,
2005; Geenen et al., 2005; Hata et al., 1999; Leopardi et al., 1997; Ogg
et al., 2004; Reynolds et al., 2002; Schumacher et al., 2005; Wagenaar
et al., 1995). It follows that Us3 would need to localize to multiple
subcellular compartments to carry out its different functions. Indeed,
detailed analysis of subcellular localization of the PRV Us3 orthologuemids encoding mCherry-HSV-2 KD/K220M Us3 or PRV KD/K137M-mRFP1 Us3. At 24 h
by confocal microscopy. Representative images are shown.
Fig. 8. Predicted leucine-rich NESs in Us3. (A) Predicted leucine-rich NESs in HSV-2 Us3.
The top line depicts the most promiscuous consensus sequence encompassing 72% of
experimentally veriﬁed leucine-rich NESs (la Cour et al., 2004); x's correspond to any
amino acid. Below are two tracts of sequence from HSV-2 Us3, designated 1 and 2, that
ﬁt this consensus sequence; amino acids corresponding to the x's in the consensus
sequence are shown in smaller font. Numbers in brackets below each predicted HSV-2
Us3 NES indicate the NES designation along with amino acid numbers that constitute
the NES. (B) Alignment of Us3 orthologues from other alphaherpesviruses. A portion of
a multiple sequence alignment of Us3s from HSV-2, HSV-1, PRV, MDV, varicella zoster
virus (VZV), bovine herpesvirus type 1 (BHV-1), and equine herpesvirus type 1 (EHV-1)
generated using ClustalW v1.4 multiple sequence alignment software with a blosum
similarity matrix is shown. Numbers in brackets correspond to the amino acid numbers
of the portion of the protein shown. Identical amino acids are indicated with an
asterisk; conserved amino acids are indicated with a period. Arrows above the
alignment indicate the amino acids that constitute the two predicted leucine-rich NESs
in HSV-2 Us3. The yes (Y) or no (N) designations at the far right indicate whether a
sequence conforming to the consensus sequence shown in panel A is present in the
portion of the Us3 protein shown.
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membrane localization signals (Calton et al., 2004; VanMinnebruggen
et al., 2003). It is expected that active transport of HSV-2 Us3 is
required in order to move this protein into or out of the nucleus
because it has a predicted molecular mass of 53 kDa, which is larger
than the limit for passive diffusion of molecules through nuclear pores
(Tran andWente, 2006). It is known that Us3 interacts with substrates
in both the nucleus and cytoplasm (Mou et al., 2007; Munger and
Roizman, 2001; Poon et al., 2003; Van den Broeke et al., 2009b).
Nuclear shuttling would allow Us3 to access substrates that are
located exclusively in either the nucleus or the cytoplasm and allow
continued access to a substrate if the subcellular localization of that
substrate changes. Thus, maintaining the ability to shuttle between
the nucleus and cytoplasm is likely vital for Us3 to carry out its
different functions.
In our current model for nuclear shuttling of HSV-2 Us3, nuclear
import proceeds via an intrinsic, non-canonical NLS or by interaction
with a cellular protein carrying an NLS. Export of HSV-2 Us3 proceeds
via a leucine-rich NES that may reside within amino acids 242–259
(Fig. 8A). This process is sensitive to LMB, implicating the speciﬁc
involvement of the chromosomal regional maintenance 1 (CRM1)-
mediated nuclear export pathway (Fornerod et al., 1997). Our studies
do not allow us yet to distinguish whether cytoplasmic accumulation
of KD/K220 mutants arises as a result of impaired nuclear import or
enhanced nuclear export of Us3. This will be an important issue to
resolve in our continuing studies on this protein.
Our previous studies on PRV Us3 demonstrated that determinants
of nuclear localization are contained within amino acids 54 through
156 (Calton et al., 2004). The lysine that we have identiﬁed as
important for proper nuclear localization does fall within the
analogous N-terminal region of HSV-2 Us3 (amino acids 64 through
241 using ClustalW v1.4 multiple sequence alignment software with a
blosum similarity matrix). Mutation of the analogous lysine in PRV
Us3, however, did not result in nuclear exclusion (Fig. 7). Also, thepotential NESs we have identiﬁed in HSV-2 Us3 are not found in the
corresponding region of PRV Us3 (Fig. 8B) and the NetNES 1.1
algorithm (la Cour et al., 2004) did not predict any amino acids having
the potential to be part of a leucine-rich NES in PRV Us3. Thus, the
speciﬁc requirements and/or mechanisms for nuclear localization of
PRV Us3 may be different from those of HSV-2 Us3.
We noted that LMB treatment of HSV-2 Us3-transfected cells
correlatedwith failure toproduce FPs (Fig. 10A).Weascribed this result
to an inability of HSV-2 Us3 to be exported to the cytoplasmwhere it is
required to elicit FPs. However, it is formally possible that LMB inhibits
FP formation in a manner that is independent of its effects on Us3
localization. To address this, experiments are underway to deﬁne the
sequence requirements of the NES of HSV-2 Us3. This will enable the
construction ofUs3mutants that are unable to localize to the cytoplasm
and allow us to test the idea that cytoplasmic Us3 is required for FP
formation without the use of pharmacological inhibitors.
Based on our current understanding of the requirements for
proper nuclear localization of HSV-2 Us3, the more pragmatic choice
of KD mutant for use in studies where nuclear localization of Us3 is
required would be KD/D305A. Our current efforts to map the NES of
HSV-2 Us3 as well as to determine whether HSV-2 Us3 contains an
intrinsic NLS will be valuable lines of investigation. A more thorough
understanding of the nuclear shuttling properties of Us3 will enable
speciﬁc disruption of nuclear shuttling as a means of studying Us3
functions in distinct cellular compartments.
Materials and methods
Cells and viruses
African green monkey kidney (Vero), 293T and HeLa cells were all
maintained in Dulbecco's modiﬁed Eagle's medium (DMEM) supple-
mented with 10% fetal calf serum in a 5% CO2 environment. HSV-1
strain 17+ and HSV-2 strain HG52 were generously provided by Drs.
A. Dolan and D. McGeoch, MRC Virology Unit, University of Glasgow.
HSV-1 and HSV-2 strains were propagated and titred on Vero cells.
Construction of Us3 expression plasmids and kinase dead versions of Us3
To construct the HSV-2 Us3 expression plasmid pHSV2Us3, the
Us3 gene was ampliﬁed by PCR with forward primer 5′CCGAATT-
CATGGCCTGTCGTAAGTTCTGTGG3′ and reverse primer 5′CCGAATTCT-
CACTTAGGGTGAAATAGCG3′ from template pATHSV-2HindIIIL (a
kind gift from Drs. A. Dolan and D. McGeoch), which contains a Hin-
dIII fragment encompassing a portion of the unique short region of the
HG52 genome (Dolan et al., 1998), and the ampliﬁed fragment was
subcloned into pCR-Blunt II-TOPO vector (Invitrogen, Burlington, ON)
by using manufacturer's protocols. All plasmids utilizing PCR in their
construction were sequenced to ensure that no spurious mutations
were introduced in the process. An EcoRI fragment encompassing the
ampliﬁed sequences was excised from this intermediate vector,
puriﬁed, and then ligated to similarly digested pCINeo vector
(Promega, Madison, WI). To fuse the red ﬂuorescent protein
monomeric Cherry (mCherry) (Shaner et al., 2004) to the N-terminus
of HSV-2 Us3, the mCherry gene was ampliﬁed by PCR with forward
primer 5′CGCGCTAGCATGGTGAGCAAGGGCGAGG3′ and reverse
primer 5′CGCCTCGAGTCTTGTACAGCTCGTCCATGC3′ from template
pRSETb mCherry (a kind gift from Dr. R. Tsien) and the ampliﬁed
fragment was subcloned into pCR-Blunt II-TOPO vector. An NheI/XhoI
fragment encompassing the ampliﬁed sequences was excised from
this intermediate vector, puriﬁed and ligated to similarly digested
pHSV2Us3. To fuse green ﬂuorescent protein (GFP) or mCherry to the
C-terminus of HSV-2 Us3, the Us3 gene was ampliﬁed by PCR with
forward primer 5′ACAAAGCTTATGGCCTGTCGTAAGTTCTGTGG3′ and
reverse primer 5′ACAGGTACCGTCTTAGGGTGAAATAGCGG3′ from
template pHSV2Us3 and the ampliﬁed fragment was subcloned into
Fig. 9. Subcellular localization of HSV-2 Us3 in the presence of LMB. Vero cells were transfected with plasmids encoding the indicated proteins. At 6 h post transfection cells were
placed in medium containing 10 nM LMB (+ LMB) or 0.07% methanol carrier (− LMB). Cells were incubated in the continuous presence of drug or carrier for 16 h, then ﬁxed and
stained with rat polyclonal antiserum speciﬁc for HSV-2 Us3 followed by staining with an Alexa 488 conjugated secondary antibody. Nuclei were stained with Hoechst 33342.
Stained cells were examined by confocal microscopy. A large proportion of transfected cells treated with LMB showed the staining pattern depicted in the “+ LMB” panels.
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ampliﬁed sequences were excised from the intermediate vector,
puriﬁed and ligated to similarly digested pEGFP-N1 (Clontech,
Mountain View, CA) or pJR70, a pEGFP-N1-based expression vector
in which the EGFP gene was replaced with the mCherry gene
(Banﬁeld and Randall, unpublished). To fuse glutathione S-transferase
(GST) to the N-terminus of HSV-2 Us3, the Us3 gene was ampliﬁed by
PCR with forward primer 5′ACAGAATTCGATGGCCTGTCG-
TAAGTTCTGTGG3′ and reverse primer 5′CCGAATTCTCACTTAGGGT-
GAAATAGCG3′ from template pHSV2Us3 and the ampliﬁed fragment
was subcloned into pCR-Blunt II-TOPO vector. An EcoRI fragment
encompassing the ampliﬁed sequences was excised from the
intermediate vector, puriﬁed and ligated to similarly digested pGEX-
3X vector (GE Healthcare Lifesciences, Piscataway, NJ).
PCR with mutagenic primers using pHSV2Us3 template DNA was
used to introduce speciﬁc mutations into the HSV-2 Us3 gene: for the
K220M mutation, we used forward primer 5′CGGGTAATCGT-
CATGGCGGGGTGGTACG3′ and reverse primer 5′CGTACCACCCCGC-
CATGACGATTACCCG3′; for the D305A mutation, we used forward
primer 5′GCAAAGGCATCATCCACCGCGCTATTAAGACCGAGAA-
CATCTTC3′ and reverse primer 5′GAAGATGTTCTCGGTCTTAA-
TAGCGCGGTGGATGATGCCTTTGC3′; for the K220A mutation, we
used forward primer 5′CATCGGGTAATCGTCGCGGCGGGGTGGTACG3′
and reverse primer 5′CGTACCACCCCGCCGCGACGATTACCCGATG3′. To
introduce the KD/K137M mutation into the PRV Us3 gene, we used
forward primer 5′CACGGTGGTGCTGATGGTGGGCCAGAAGC3′ and
reverse primer 5′GCTTCTGGCCCACCATCAGCACCACCGTG3′ on
pPRVUs3bmRFP1 template, a pCINeo-based plasmid containing Us3sequence derived from the Becker strain of PRV with monomeric red
ﬂuorescent protein (mRFP1) (Campbell et al., 2002) fused to the C-
terminus. GFP or mCherry was introduced on to the N- or C-terminus
of KD versions of HSV-2 Us3 as described above for thewild type (WT)
protein or by directly using WT fusion protein expression plasmids as
template for mutagenesis.
Preparation of HSV-2 Us3 antiserum
A baculovirus expression system, generously provided by Dr. E.
Carstens, Queen's University, was used to express GST-HSV-2 Us3. The
GST-HSV-2 Us3 gene was ampliﬁed by PCR with forward primer 5′
CGCCTCGAGATGTCCCCTATACTAGG3′ and reverse primer 5′
CGCAAGCTTGAATTCTCACTTAGGGTG3′ from pGEX-3X vector contain-
ing HSV-2 Us3 sequence (see preceding section) and the ampliﬁed
fragment was subcloned into pCR-Blunt II TOPO vector. An XhoI and
HindIII fragment encompassing the ampliﬁed sequences was excised
from the intermediate vector, puriﬁed and ligated to similarly
digested pFast-Bac1 vector to form pFast-Bac-GST-HSV2Us3.
DH10Bac E. coli cells, containing bacmid vector, were transformed
with pFast-Bac-GST-HSV2Us3. To screen for incorporation of GST-
HSV-2 Us3 into the Baculovirus genome, transformants were
subjected to blue/white screening on selection plates containing
kanamycin (50 μg/ml), gentamycin (7 μg/ml), tetracycline (10 μg/
ml), X-gal (100 μg/ml), and IPTG (40 μg/ml). Recombinant bacmid
DNAwas puriﬁed using the Bac-to-Bac Baculovirus Expression System
(Invitrogen, Burlington, ON), according to manufacturer's procedures
and then used to transfect Sf21 cells. Cell supernatants containing
Fig. 10. FP formation in the presence of LMB. (A) Percentage of transfected cells with FPs. Vero cells were transfected in duplicate with plasmids encoding the indicated proteins. At
6 h post transfection cells were placed in medium containing 10 nM LMB or 0.07% methanol carrier. Cells were incubated in the continuous presence of drug or carrier for 16 h, then
ﬁxed and stained with rat polyclonal antiserum speciﬁc for HSV-2 Us3 followed by staining with an Alexa 488 conjugated secondary antibody. Nuclei were stained with Hoechst
33342. Stained cells were examined by confocal microscopy and transfected cells were scored for the presence or absence of FPs. The average of duplicate samples is shown. Numbers
of cells scored are as follows: for Us3-transfected cells treated with carrier, 137 and 135; for Us3-transfected cells treated with LMB, 101 and 106; for mCherry-transfected cells
treated with carrier, 122 and 134; for mCherry-transfected cells treated with LMB, 104 and 103. (B) Images of transfected cells used in this analysis. A large proportion of transfected
cells treated with LMB showed the staining pattern depicted in the “+ LMB” panels.
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recombinant virus was plaque puriﬁed. Sf21 cells (2×106) seeded
onto a T25 ﬂaskwere infectedwith recombinant virus at a multiplicity
of infection (MOI) of 0.1. At 72 h post infection cells were harvested
and centrifuged for 5 min at 3000×g. Supernatant was discarded and
pelleted cells were lysed with 1 ml of cold buffer C (50 mM Tris [pH
7.5], 100 mM NaCl, 5 mM MgCl2, 0.1% NP-40, 10% glycerol, and 1 mM
PMSF) (Kato et al., 2001). Cell lysate was centrifuged at 5000×g for
20 min, and insoluble material in the pellet was separated by SDS-
PAGE on a 10% acrylamide gel. A band corresponding to the 78-kDa
GST-HSV-2 Us3 fusion protein was excised from the gel and used to
immunize rats for antibody production (Cedarlane Laboratories,
Burlington, ON). Rat polyclonal antiserum against HSV-2 Us3 was
used for Western blotting at a dilution of 1:500 and for indirect
immunoﬂuorescence microscopy at a dilution of 1:1000.
Other immunological reagents
Anti β-actin monoclonal antibody (Sigma, St. Louis, MO) was used
for Western blotting at a dilution of 1:2000; anti β-tubulin
monoclonal antibody (Sigma, St. Louis, MO) was used for indirect
immunoﬂuorescence at a dilution of 1:200; anti ICP5 monoclonal
antibody (Virusys, Sykesville, MD) was used for Western blotting at adilution of 1:3000; anti ICP8 monoclonal antibody (Virusys, Sykes-
ville, MD) was used for indirect immunoﬂuorescence at a dilution of
1:1000; Phospho-(Ser/Thr) PKA substrate antibody (Cell Signaling
Technology, Danvers, MA) was used for Western blotting at a dilution
of 1:1000; horseradish peroxidase conjugated goat anti-mouse, goat
anti-rabbit and rabbit anti-rat (Sigma, St. Louis, MO) were used for
Western blotting at dilutions of 1:10,000, 1:10,000 and 1:80,000,
respectively; Alexa Fluor 488 conjugated donkey anti-rat, Alexa Fluor
568 conjugated donkey anti-mouse, and Alexa Fluor 647 conjugated
donkey anti-mouse (Invitrogen, Burlington, ON) were all used for
indirect immunoﬂuorescence at a dilution of 1:500.
Transfections
Transfection of 293T cells for the purpose of preparing cellular
extracts was carried out using the calcium phosphate co-precipitation
technique (Graham and van der Eb, 1973). Transfection of Vero, 293T
and HeLa cells for the purpose of microscopic analyses was carried out
using FuGene 6 (Roche, Laval, QC) according to manufacturer's
instructions. Transfection of Vero cells for the purpose of preparing
whole cell extracts was carried out using the Amaxa Nucleofector
transfection system (Lonza, Basel, Switzerland) according to manu-
facturer's instructions.
Fig. 11. Us3 localization in HSV-2 infected cells in the presence or absence of LMB. Vero cells were infectedwith HSV-2 HG52 at anMOI of 10. At 2 h post infection cells were placed in
medium containing 10 nM LMB (+ LMB) or 0.07% methanol carrier (− LMB). Cells were incubated in the continuous presence of drug or carrier for 6 h, then ﬁxed and stained with
rat polyclonal antiserum speciﬁc for HSV-2 Us3 and mouse monoclonal antibody speciﬁc for ICP8, followed by staining with Alexa 488 conjugated donkey anti-rat and Alexa 568
conjugated donkey anti-mouse secondary antibodies. Nuclei were stained with Hoechst 33342. Stained cells were examined by confocal microscopy. Representative images are
shown.
32 R.L. Finnen et al. / Virology 397 (2010) 23–33Preparation and analysis of cellular extracts
For preparation of cellular extracts from infected cells, conﬂuent
monolayers of Vero cells grown in six-well plates were infected with
HSV-1 or HSV-2 at anMOI of 1. At 24 h post infection, themediumwas
removed and the cells were washed with phosphate-buffered saline
(PBS). Cells were scraped into 200 μl of lysis buffer (10 mM Tris [pH
7.4], 150mMNaCl, 1% NP40, 1% Na deoxycholate) containing protease
inhibitors (Roche, Laval, QC) and transferred to a 1.5-ml microfuge
tube. Lysates were kept on ice for 30 min with intermittent mixing
and then centrifuged at 10,000×g for 5 min. Supernatants were
collected in 1.5-ml microfuge tubes and stored at −20 °C. For
preparation of cellular extracts from transfected 293T cells, subcon-
ﬂuent monolayers of cells grown in 35-mmdishes were transfected as
described in the preceding section. At 24 h post transfection, extracts
were prepared and stored as described above. For Western blot
analysis, 5–10 μl of cellular extract was mixed with SDS-PAGE loading
buffer, heated to 100 °C for 5 min, and electrophoresed through SDS-
12.5% PAGE gels. Separated proteins were transferred to PVDF
membranes (Millipore, Billerica, MA) and probed with appropriate
dilutions of primary antibody followed by appropriate dilutions of
horseradish peroxidase conjugated secondary antibody. For prepara-
tion of whole cell extracts from transfected Vero cells, 1×106 cells
grown in 35-mm dishes were transfected using the Amaxa Nucleo-
fector system. At 24 h post transfection, cells were scraped off the dish
in 100 μl of PBS, transferred to a 1.5-ml microfuge tube and lysed by
the addition of 33 μl of 3× SDS-PAGE loading buffer. The lysate was
repeatedly passed through a 28 1/2 gauge needle to reduce viscosity
and then heated at 100 °C for 5 min. Twenty microliters of whole cell
lysate was used for Western blot analysis as described above.
Inhibition of actin polymerization
To inhibit actin polymerization in Us3-transfected Vero cells, cells
were incubated in medium containing either 1 μM cytochalasin D or
0.01% DMSO (carrier) starting at 6 h post transfection. Cells were
maintained in the continuous presence of cytochalasin D or carrier for
a total of 12 h.
Indirect immunoﬂuorescence microscopy
Cells formicroscopic analyseswere grown either on glass coverslips
or on glass bottom dishes (MatTek, Ashland, MA). Cells were ﬁxed byincubation with freshly prepared 4% paraformaldehyde in PBS for
10min at room temperature. Fixed cells werewashed three timeswith
PBS containing 1% BSA (PBS/BSA) and permeabilized for 10 min at
room temperature with PBS/BSA containing 0.1% Triton X-100. Cells
were then washed three times with PBS/BSA and 150 μl of primary
antiserum diluted appropriately in PBS/BSA was applied for 45 min at
room temperature. Cells were washed three times with PBS/BSA and
150 μl of Alexa Fluor conjugated secondary antibody (Invitrogen,
Burlington, ON) diluted appropriately in PBS/BSA was applied for
30 min at room temperature. Cells were then washed three times with
PBS/BSA. To visualize nuclei, cells were incubated with Hoechst 33342
(Sigma, St. Louis, MO) diluted to 0.5 μg/ml in PBS for 7 min at room
temperature. To visualize ﬁlamentous actin, cells were incubated with
Texas Red-phalloidin (Invitrogen, Burlington, ON) diluted to 165 nM in
PBS for 7 min at room temperature. Stained cells on coverslips were
washed 3 times in PBS and mounted in PBS containing 50% (v/v)
glycerol onto glass slides; stained cells in glass bottom dishes were
washed three times in PBS and stored under PBS/BSA. Images were
captured using anOlympus FV1000 laser scanning confocalmicroscope
and FluoviewCS3 software. Imageswere captured using a 40×or a 60×
objective and a digital zoom factor ranging from 2 to 4. Composites of
representative imageswere prepared usingAdobe Photoshop software.
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